Volume 27, Number 9—September 2021
Research
Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, India
Figure 1

Figure 1. Locations of 16 healthcare centers participating in MucoCovi Network study on coronavirus disease–associated mucormycosis, India. AIIMS, All India Institute of Medical Sciences; CIMS, Care Institute of Medical Sciences; PD Hinduja, Parmanand Deepchand Hinduja; PGIMER, Post Graduate Institute of Medical Education & Research; SGPI, Sanjay Gandhi Postgraduate Institute
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
3Members are listed at the end of this article.
Page created: June 02, 2021
Page updated: August 17, 2021
Page reviewed: August 17, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.